Bodenstein, David F.
Powlowski, Pavel
Zachos, Kassandra A.
El Soufi El Sabbagh, Dana
Jeong, Hyunjin
Attisano, Liliana
Edgar, Landon
Wallace, Douglas C.
Andreazza, Ana Cristina http://orcid.org/0000-0002-4323-7273
Funding for this research was provided by:
New Frontiers in Research Fund (#NFRFE-2019-00100)
Article History
Received: 28 November 2022
Accepted: 27 July 2023
First Online: 15 August 2023
Declarations
:
: Title: Using autologous mitochondrial transplant to decrease or stabilize heteroplasmy levels in mitochondrial disease; REB# 40505, University of Toronto, Health Science Committee; Approved Date: 04.02.2021, Expiry Date: 03.02.2024.
: Not applicable.
: The authors declare that they have no competing interests.